BRPI0412905A - composição farmacêutica como forma de dosagem sólida e método de fabricação - Google Patents
composição farmacêutica como forma de dosagem sólida e método de fabricaçãoInfo
- Publication number
- BRPI0412905A BRPI0412905A BRPI0412905-9A BRPI0412905A BRPI0412905A BR PI0412905 A BRPI0412905 A BR PI0412905A BR PI0412905 A BRPI0412905 A BR PI0412905A BR PI0412905 A BRPI0412905 A BR PI0412905A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- dosage form
- solid dosage
- manufacturing
- desmopressin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"COMPOSIçãO FARMACêUTICA COMO FORMA DE DOSAGEM SóLIDA E MéTODO DE FABRICAçãO". A presente invenção refere-se a uma nova composição farmacêutica como forma de dosagem sólida compreendendo desmopressina como ingrediente terapeuticamente ativo, e a um método para fabricar o mesmo. A invenção refere-se a uma composição farmacêutica como forma de dosagem sólida compreendendo desmopressina, ou um sal farmaceuticamente aceitável da mesma, como um ingrediente terapeuticamente ativo junto com um excipiente, diluente ou veículo farmaceuticamente aceitável, ou mistura dos mesmos, em que a composição farmacêutica é composta de um granulado compreendendo e contém lubrificante em uma quantidade de 0,05 a menos que 0,5 por cento em peso da dita composição farmacêutica.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/626,857 US7022340B2 (en) | 2003-07-25 | 2003-07-25 | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
| EP03016945A EP1500390B1 (en) | 2003-07-25 | 2003-07-25 | Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof |
| PCT/EP2004/051538 WO2005011640A2 (en) | 2003-07-25 | 2004-07-19 | Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0412905A true BRPI0412905A (pt) | 2006-09-26 |
Family
ID=34117527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0412905-9A BRPI0412905A (pt) | 2003-07-25 | 2004-07-19 | composição farmacêutica como forma de dosagem sólida e método de fabricação |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7022340B2 (pt) |
| EP (1) | EP1500390B1 (pt) |
| JP (1) | JP4430673B2 (pt) |
| KR (1) | KR20050104331A (pt) |
| AT (1) | ATE301990T1 (pt) |
| AU (1) | AU2004260625B2 (pt) |
| BR (1) | BRPI0412905A (pt) |
| CA (1) | CA2490335C (pt) |
| DE (1) | DE60301351T2 (pt) |
| DK (1) | DK1500390T3 (pt) |
| ES (1) | ES2243840T3 (pt) |
| HK (1) | HK1072009A1 (pt) |
| IL (1) | IL187591A0 (pt) |
| MX (1) | MXPA06000903A (pt) |
| NO (1) | NO327328B1 (pt) |
| NZ (1) | NZ544104A (pt) |
| PL (1) | PL379704A1 (pt) |
| PT (1) | PT1500390E (pt) |
| RU (1) | RU2303439C2 (pt) |
| SI (1) | SI1500390T1 (pt) |
| TW (1) | TWI268782B (pt) |
| WO (1) | WO2005011640A2 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
| US7094545B2 (en) * | 2003-04-30 | 2006-08-22 | Ferring Bv | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
| CN1826099B (zh) * | 2003-07-25 | 2010-06-09 | 凡林有限公司 | 固体剂型药物组合物及其制造方法 |
| ES2260563T3 (es) * | 2003-11-13 | 2006-11-01 | Ferring B.V. | Paquete de blister y forma farmaceutica solida para ello. |
| US7018653B2 (en) * | 2003-12-29 | 2006-03-28 | Ferring B.V. | Method for preparing solid dosage form of desmopressin |
| CA2490601C (en) * | 2003-12-29 | 2006-05-02 | Ferring B.V. | Method for preparing solid dosage form of desmopressin |
| SE528446C2 (sv) * | 2006-03-02 | 2006-11-14 | Ferring Int Ct Sa | Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse |
| CA2695634C (en) | 2007-08-06 | 2018-01-23 | Serenity Pharmaceuticals Corporation | Methods and devices for desmopressin drug delivery |
| ES2319054B1 (es) | 2007-08-06 | 2010-02-12 | Gp Pharm S.A. | Composicion farmaceutica oral de desmopresina. |
| US20090232896A1 (en) * | 2008-03-11 | 2009-09-17 | Mallinckrodt Inc. | Use of Magnesium Stearate Dihydrate for Lubrication of Solid Pharmaceutical Compositions |
| US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
| DK3225250T3 (da) * | 2008-05-21 | 2019-11-04 | Ferring Bv | Orodispersibel desmopressin til forlængelse af den indledende søvnperiode, som ikke forstyrres af nykturi |
| US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
| KR20110089265A (ko) * | 2008-09-30 | 2011-08-05 | 미쓰이 가가쿠 가부시키가이샤 | 섬유 강화 수지 조성물 및 그의 성형체 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8306367L (sv) * | 1983-11-18 | 1985-05-19 | Ferring Ab | Antidiuretiskt verkande farmaceutiskt preparat |
| US4675188A (en) * | 1985-08-02 | 1987-06-23 | Stauffer Chemical Company | Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting |
| US4820627A (en) * | 1986-03-24 | 1989-04-11 | Em Diagnostic Systems, Inc. | Method of preparing particles suitable for tabletting into diagnostic reagents |
| US5482931A (en) | 1993-06-29 | 1996-01-09 | Ferring Ab | Stabilized pharmaceutical peptide compositions |
| WO1995018602A1 (en) | 1994-01-11 | 1995-07-13 | Alkermes Controlled Therapeutics, Inc. | ORAL DOSAGE FORM OF DESMOPRESSIN (dDAVP) |
| SE9400918L (sv) | 1994-03-18 | 1995-09-19 | Anne Fjellstad Paulsen | Stabiliserad komposition för oral administrering av peptider |
| US5849322A (en) | 1995-10-23 | 1998-12-15 | Theratech, Inc. | Compositions and methods for buccal delivery of pharmaceutical agents |
| GB9526495D0 (en) | 1995-12-23 | 1996-02-28 | Knoll Ag | Therapeutic agents |
| DE19602757A1 (de) * | 1996-01-26 | 1997-07-31 | Boehringer Mannheim Gmbh | Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung |
| WO2000009423A1 (es) | 1998-08-11 | 2000-02-24 | Jaime Marti Sala | Silo para almacenamiento de cuerpos huecos ligeros |
| AT409081B (de) | 2000-02-16 | 2002-05-27 | Gebro Pharma Gmbh | Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung |
| WO2001078696A2 (en) | 2000-04-17 | 2001-10-25 | Vectura Limited | Formulations for use in inhaler devices |
| GB0009469D0 (en) * | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices |
| PE20011227A1 (es) * | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
| GB0010709D0 (en) | 2000-05-03 | 2000-06-28 | Vectura Ltd | Powders for use a in dry powder inhaler |
| WO2002000197A1 (en) | 2000-06-27 | 2002-01-03 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| PL367957A1 (en) | 2001-10-15 | 2005-03-07 | Röhm Gmbh & Co.Kg | Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent |
| DE60307082D1 (de) | 2002-05-07 | 2006-09-07 | Ferring Bv | In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin |
| EP1473029B1 (en) * | 2003-04-30 | 2005-03-23 | Ferring B.V. | Solid dosage form comprising desmopressin |
| US7094545B2 (en) * | 2003-04-30 | 2006-08-22 | Ferring Bv | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
-
2003
- 2003-07-25 ES ES03016945T patent/ES2243840T3/es not_active Expired - Lifetime
- 2003-07-25 DK DK03016945T patent/DK1500390T3/da active
- 2003-07-25 SI SI200330100T patent/SI1500390T1/sl unknown
- 2003-07-25 DE DE60301351T patent/DE60301351T2/de not_active Expired - Lifetime
- 2003-07-25 AT AT03016945T patent/ATE301990T1/de active
- 2003-07-25 US US10/626,857 patent/US7022340B2/en not_active Expired - Fee Related
- 2003-07-25 PT PT03016945T patent/PT1500390E/pt unknown
- 2003-07-25 EP EP03016945A patent/EP1500390B1/en not_active Revoked
-
2004
- 2004-07-19 NZ NZ544104A patent/NZ544104A/en not_active IP Right Cessation
- 2004-07-19 BR BRPI0412905-9A patent/BRPI0412905A/pt not_active Application Discontinuation
- 2004-07-19 KR KR1020057006309A patent/KR20050104331A/ko not_active Application Discontinuation
- 2004-07-19 RU RU2005141230/15A patent/RU2303439C2/ru not_active IP Right Cessation
- 2004-07-19 AU AU2004260625A patent/AU2004260625B2/en not_active Ceased
- 2004-07-19 CA CA002490335A patent/CA2490335C/en not_active Expired - Fee Related
- 2004-07-19 WO PCT/EP2004/051538 patent/WO2005011640A2/en active Application Filing
- 2004-07-19 PL PL379704A patent/PL379704A1/pl not_active Application Discontinuation
- 2004-07-19 JP JP2006520833A patent/JP4430673B2/ja not_active Expired - Fee Related
- 2004-07-19 MX MXPA06000903A patent/MXPA06000903A/es active IP Right Grant
- 2004-07-23 TW TW093122090A patent/TWI268782B/zh not_active IP Right Cessation
-
2005
- 2005-04-19 NO NO20051896A patent/NO327328B1/no not_active IP Right Cessation
- 2005-06-13 HK HK05104919A patent/HK1072009A1/xx not_active IP Right Cessation
-
2007
- 2007-11-22 IL IL187591A patent/IL187591A0/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200509995A (en) | 2005-03-16 |
| CA2490335A1 (en) | 2005-01-25 |
| EP1500390B1 (en) | 2005-08-17 |
| NZ544104A (en) | 2008-06-30 |
| DE60301351D1 (de) | 2005-09-22 |
| WO2005011640A2 (en) | 2005-02-10 |
| KR20050104331A (ko) | 2005-11-02 |
| RU2303439C2 (ru) | 2007-07-27 |
| ATE301990T1 (de) | 2005-09-15 |
| IL187591A0 (en) | 2008-03-20 |
| MXPA06000903A (es) | 2006-05-04 |
| US7022340B2 (en) | 2006-04-04 |
| PL379704A1 (pl) | 2006-11-13 |
| DE60301351T2 (de) | 2006-01-19 |
| AU2004260625A1 (en) | 2005-02-10 |
| NO20051896L (no) | 2005-04-19 |
| PT1500390E (pt) | 2005-10-31 |
| EP1500390A1 (en) | 2005-01-26 |
| SI1500390T1 (sl) | 2006-02-28 |
| RU2005141230A (ru) | 2006-07-10 |
| ES2243840T3 (es) | 2005-12-01 |
| CA2490335C (en) | 2006-01-31 |
| WO2005011640A3 (en) | 2005-03-24 |
| US20050019392A1 (en) | 2005-01-27 |
| AU2004260625B2 (en) | 2007-12-06 |
| HK1072009A1 (en) | 2005-08-12 |
| NO327328B1 (no) | 2009-06-08 |
| TWI268782B (en) | 2006-12-21 |
| JP2007517762A (ja) | 2007-07-05 |
| JP4430673B2 (ja) | 2010-03-10 |
| DK1500390T3 (da) | 2005-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1072009A1 (en) | Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof. | |
| TW200518743A (en) | Rapid dissolution formulation of a calcium receptor-active compound | |
| MY144477A (en) | Galenic formulations of organic compounds | |
| WO2006024486A3 (en) | Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents | |
| WO2006119504A3 (en) | Fused heterocyclic compounds, and compositions and uses thereof | |
| UA85708C2 (ru) | Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей | |
| WO2003022809A3 (en) | Urea-compounds active as vanilloid receptor antagonists for the treatment of pain | |
| EA200401583A1 (ru) | Таблетка лазофоксифена и ее покрытие | |
| WO2005061467A3 (en) | Piperazine derivatives as bradykinin antagonists | |
| EA200301040A1 (ru) | Способ производства фармацевтической композиции низкой дозы | |
| TW200640465A (en) | New pharmaceutically active compounds for the treatment of respiratory diseases | |
| TW200800984A (en) | New compounds | |
| WO2006029210A3 (en) | Acyclic 1,3-diamines and uses therefor | |
| SE0401655D0 (sv) | New compounds | |
| WO2008023003A8 (de) | Arzneimittelkombinationen zur behandlung von atemwegserkrankungen | |
| GB0212410D0 (en) | Organic compounds | |
| TW200640472A (en) | Solid pharmaceutical composition comprising telithromycin | |
| SE0000303D0 (sv) | Novel compounds | |
| PT1473029E (pt) | Forma de dosagem solida compreendendo desmopressina | |
| IL163025A (en) | Prucalopride - n - oxides, their preparation and pharmaceutical compositions comprising them | |
| EA200401082A1 (ru) | Новые соединения бензоиндолина, способ их получения и фармацевтические композиции, которые их содержат | |
| AR046261A1 (es) | Composicion farmaceutica como forma de dosificacion solida y metodo para su fabricacion | |
| TH80175B (th) | สารสำหรับการใช้ในการบำบัดโรคเรื้อนกวาง | |
| HRP20110563T1 (en) | Salt of 4[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |